Skip to content
GenoLensGenoLens

AGXT

Chr 2q37.3

alanine--glyoxylate aminotransferase

Aliases:
AGXT1, PH1, AGT, SPT, AGT1
MANE:
ENST00000307503.4

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary neuropathy or pain disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Nephrocalcinosis or nephrolithiasis

    BIALLELIC, autosomal or pseudoautosomal
  • Peroxisomal disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary neuropathy

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal

+2 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • primary hyperoxaluria type 1

    0.86
  • primary hyperoxaluria

    0.73
  • alanine glyoxylate aminotransferase deficiency

    0.49
  • hereditary disease

    0.49
  • Hyperoxaluria

    0.46
  • nephrocalcinosis

    0.37
  • nephrolithiasis

    0.37
  • nephrotic syndrome

    0.35
  • Abnormality of metabolism/homeostasis

    0.27
  • cardiac arrhythmia

    0.27

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Alanine--glyoxylate aminotransferase

Peroxisomal aminotransferase that catalyzes the transamination of glyoxylate to glycine and contributes to the glyoxylate detoxification (PubMed:10960483, PubMed:12777626, PubMed:23229545, PubMed:24055001, PubMed:26149463). Also catalyzes the transamination between L-serine and pyruvate and contributes to gluconeogenesis from the L-serine metabolism (PubMed:10347152)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.